IceCure Medical Ltd. - Ordinary Shares (ICCM)
1.4800
+0.0100 (0.68%)
Icecure Medical Ltd is a pioneering medical technology company that specializes in the development and commercialization of innovative treatments for cancer using its proprietary cryoablation technology
This minimally invasive approach involves the use of extreme cold to target and destroy cancerous cells while preserving surrounding healthy tissue. The company focuses on providing effective solutions for a range of tumors, positioning its products to improve patient outcomes and enhance the overall experience of cancer treatment. Through ongoing research and collaboration with healthcare professionals, Icecure aims to advance the field of oncology and offer patients safer, less invasive alternatives to traditional therapies.
Previous Close | 1.470 |
---|---|
Open | 1.480 |
Bid | 1.470 |
Ask | 1.480 |
Day's Range | 1.430 - 1.500 |
52 Week Range | 0.4800 - 1.660 |
Volume | 125,954 |
Market Cap | - |
PE Ratio (TTM) | - |
EPS (TTM) | - |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 396,946 |
News & Press Releases

ICCM stock results show that Icecure Medical beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 20, 2024

IceCure Medical Ltd.
Via Benzinga · November 28, 2023

Via Benzinga · June 17, 2024

We have all of the biggest pre-market stock movers that investors are going to want to keep an eye on for Monday morning!
Via InvestorPlace · June 17, 2024

ICCM stock results show that Icecure Medical met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via InvestorPlace · May 28, 2024

New Standard of Care? IceCure Submits Final ICE3 Data To FDA, Minimally Invasive Cryoablation Shows Similar 5-year Recurrence Outcomes To Surgery With Hormone Therapy
Via News Direct · April 29, 2024

Game-Changing Tumor Freezing Technology Has The Potential To Offer Women First-Ever Minimally Invasive Alternative To Breast Lumpectomy Surgery
Via News Direct · April 12, 2024

ICCM stock results show that Icecure Medical met analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
Via InvestorPlace · April 3, 2024

Companies Reporting Before The Bell • Acuity Brands (NYSE:AYI) is projected to report quarterly earnings at $3.25 per share on revenue of $907.75 million.
Via Benzinga · April 3, 2024

CAESAREA, Israel, Jan. 12, 2024 (GLOBE NEWSWIRE) -- IceCure Medical Ltd. (Nasdaq: ICCM) (“IceCure” or the “Company”), developer of the ProSense® System, a minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced that it has received a written notice from The Nasdaq Stock Market LLC ("Nasdaq") that the Company has regained compliance with the minimum bid price requirement for continued listing set forth in Nasdaq Listing Rule 5550(a)(2), which requires listed securities, including the Company's ordinary shares, to maintain a minimum bid price of $1.00 per share.
By IceCure Medical Ltd. · Via GlobeNewswire · January 12, 2024

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 100 points on Tuesday. The Dow traded up 0.27% to 35,429.20 while the NASDAQ rose 0.12% to 14,258.32. The S&P 500 also rose, gaining, 0.07% to 4,553.52.
Via Benzinga · November 28, 2023

Shares of SenesTech, Inc. (NASDAQ: SNES) shares moved lower during Tuesday’s session after the company reported pricing of $5.0 million public offering.
Via Benzinga · November 28, 2023

Investors in IceCure Medical and ICCM stock certainly have a big catalyst to price in today. Now, shares are moving accordingly.
Via InvestorPlace · November 28, 2023

Gainers Maris-Tech Ltd. (NASDAQ: MTEK) shares rose 38% to $1.38 in pre-market trading, after gaining 6% on Friday. Maris-Tech, on Friday, disclosed the launch of Jupiter Drones, an innovative, drone-oriented solution based on Maris-Tech's Jupiter Nano platform.
Via Benzinga · October 9, 2023

Gainers VIQ Solutions Inc. (NASDAQ: VQS) shares rose 88.5% to $0.2470 in pre-market trading after falling 18% on Monday. VIQ Solutions recently announced delisting from the Nasdaq.
Via Benzinga · October 3, 2023

U.S. stocks traded mostly lower toward the end of trading, with the Dow Jones falling more than 150 points on Monday. The Dow traded down 0.49% to 33,344.27 while the NASDAQ rose 0.21% to 13,246.63. The S&P 500 also fell, dropping, 0.40% to 4,271.07.
Via Benzinga · October 2, 2023

Gainers AERWINS Technologies Inc. (NASDAQ: AWIN) shares climbed 86.1% to $0.2248 after the company said it is considering strategic alternatives for its non-core operations.
Via Benzinga · October 2, 2023

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining around 40 points on Monday. The Dow traded down 0.60% to 33,306.79 while the NASDAQ rose 0.29% to 13,257.86. The S&P 500 also fell, dropping, 0.40% to 4,270.74.
Via Benzinga · October 2, 2023

IceCure Medical Ltd (NASDAQ: ICCM) announced that new data was presented at the European Society of Breast Imaging Scientific Meeting, validating IceCure's ProSense Cryoablation is a safe and effective outpatient procedure for breast cancer with a
Via Benzinga · October 2, 2023

U.S. stocks traded mixed this morning, with the Dow Jones falling around 100 points on Monday. Following the market opening Monday, the Dow traded down 0.31% to 33,404.26 while the NASDAQ rose 0.38% to 13,269.83. The S&P 500 also fell, dropping, 0.09% to 4,284.19.
Via Benzinga · October 2, 2023

U.S. stocks traded mixed toward the end of trading, with the Dow Jones gaining around 200 points on Wednesday. The Dow traded up 0.59% to 34,720.69 while the NASDAQ fell 0.07% to 13,668.37. The S&P 500 also rose, gaining, 0.17% to 4,451.42.
Via Benzinga · September 20, 2023

Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares jumped 104.5% to $0.1916.
Via Benzinga · September 20, 2023